Table 1.
Demographic, clinical and immunological characteristics of the 547 ADR12 participants in Uganda
| Characteristics | Total |
|---|---|
| Gender | |
| male | 182 (33.3) |
| female | 365 (66.7) |
| Age, years, median (IQR) | 34 (28–41) |
| Region | |
| Central | 166 (30.3) |
| East | 69 (12.6) |
| Kampala | 34 (6.2) |
| North | 96 (17.6) |
| West | 182 (33.3) |
| CD4 count at ART initiation, cells/mm3, median (IQR) | 318 (182–450) |
| Viral loada | |
| <1000 copies/mL | 493 (92.5) |
| ≥1000 copies/mL | 40 (7.5) |
| VL among VFs, log10 copies/mL, median (IQR) | 4.6 (4.2–4.8) |
| Time on ART, months, median (IQR) | 12.9 (11.2–14.5) |
| Initial ART regimen | |
| TDF+3TC+EFV/NVP | 448 (81.9) |
| ZDV+3TC+EFV/NVP | 60 (11.0) |
| TDF+FTC+EFV | 39 (7.1) |
Values are n (%) unless otherwise stated.
a
Fourteen viral loads did not amplify.